George M Bohigian. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Administration, TopicalAnterior Chamber/drug effectsAnti-Bacterial Agents/therapeutic useAntibiotic ProphylaxisCefuroxime/therapeutic useEndophthalmitis/microbiologyEndophthalmitis/prevention & controlEuropeEye Infections, Bacterial/microbiologyEye Infections, Bacterial/prevention & controlHumansInjectionsOfloxacin/therapeutic usePhacoemulsificationPostoperative Complications/microbiologyPostoperative Complications/prevention & control
Substances： See more » Anti-Bacterial AgentsOfloxacinCefuroxime
Year: 2006 PMID： 16931233 DOI： 10.1016/j.jcrs.2006.06.013
Source DB: PubMed Journal: J Cataract Refract Surg ISSN： 0886-3350 Impact factor: 3.351